RELMADA THERAPEUTICS, INC. — Director's Dealing 2018

Oct 19, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RELMADA THERAPEUTICS, INC. (RLMD)
CIK: 0001553643
Period of Report: 2018-10-12

Reporting Person: Kelly Paul Edward (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-10-12	Common Stock	P	150000	$0.90	Acquired	160000	Direct
2018-10-18	Common Stock	C	223483	$0.72	Acquired	383483	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-10-12	Warrant	$1.5	P	97500	Acquired	2023-10-12	Common stock (97500)	Direct